Southpoint Capital Advisors LP - AIMMUNE THERAPEUTICS INC ownership

Back to all holdings Add to watchlist

AIMMUNE THERAPEUTICS INC's ticker is AIMT and the CUSIP is 00900T107. A total of 167 filers reported holding AIMMUNE THERAPEUTICS INC in Q2 2020. The put-call ratio across all filers is 0.64 and the average weighting 0.1%.

Links
Filings
External links
Quarter-by-quarter ownership
Southpoint Capital Advisors LP ownership history of AIMMUNE THERAPEUTICS INC
ValueSharesWeighting
Q2 2020$5,013,000
-72.0%
300,000
-62.5%
0.12%
-83.9%
Q1 2019$17,880,000
-6.6%
800,0000.0%0.76%
-17.9%
Q4 2018$19,136,000–800,000–0.92%–
 Download
Other shareholders

There were no reported owners of AIMMUNE THERAPEUTICS INC in Q2 2020.

NameSharesValueWeighting ↓
View complete list of AIMMUNE THERAPEUTICS INC shareholders